Almost a third of Australian haematologists and medical oncologists receive payments from the pharmaceutical industry, a rate three times higher than the average for specialist physicians, new research shows. The authors of the study say the findings are a reflection of the influence of industry in funding development of expensive novel cancer therapies rather than ...
Pharma industry payments to haematologists under the microscope
By Megan Howe
11 Aug 2020